Addiction Medicine Updates
Latest News & Upcoming Events
While opioid addiction is widely recognized as a national epidemic, one aspect of the crisis has received little attention: the short- and long-term effects on children and adolescents whose parents are addicted. An individual’s substance use disorder (SUD) sends...
RALEIGH, NC (April 2, 2019) – Stephen Wyatt, DO, medical director of Addiction Medicine at Atrium Health in Charlotte, was awarded the Frederick B. Glaser Award on March 23 at the Addiction Medicine 2019 conference held in Asheville, NC. The biennial award, given by...
In 2016, the powerful drug fentanyl claimed the life of music legend Prince and has, in recent years, largely contributed to the next wave of America’s opioid crisis. Here are 10 things you should know about fentanyl. 10 Things to Know About Fentanyl Learn more about...
Opioid Use in Pregnancy: 2018 & Beyond
Friday April 13, 2018 from 9:00 AM to 4:00 PM
This one day continuing professional development event will address challenges associated with opioid use and treatment during pregnancy. Effects of opioids on both mothers and infants will be discussed, along with community resources. The purposes of this session is to update health care professionals on opioid use during the perinatal period.
Target Audience: MDs, pharmacists, nurses, social workers, counselors, health educators, psychologists and others interested in opioid use and pregnancy.
• Discuss the scope of opioid use during the pregnant and postpartum periods.
• Explore challenges associated with neonatal abstinence syndrome.
• Identify techniques to assist mothers who are breastfeeding their opioid dependent infants.
• Recognize pharmacological considerations for patients who are dependent upon opioids.
• Create action steps to assist families struggling with opioid addiction.
Forsyth Medical Center
3333 Silas Creek Parkway
Winston Salem, NC 27103
Learn key strategies for managing opioid dependency during pregnancy and understand current treatment plans for the holistic care experience of the patient.
John M. Lafferty, MD
Dr. Lafferty is a graduated from UNC Chapel Hill and completed his residency and internships at Blodgett Memorial Medical Center in Grand Rapids, Michigan. He is Board Certified by American Board of Obstetrics and Gynecology in the specialty of Obstetrics and Gynecology.
Elizabeth “Libby” Dolen, MS, BSN, RN, NE-BC
Libby has been a Registered Nurse for 36 years with most of her career focused on Women’s and Children’s Services. She obtained her BSN from Emory University and an MS from Mountain States University. She is a Certified Nurse Executive by the American Nurses’ Credentialing Center. Currently, she serves as the Director of Nursing Practice for the Family Center and the Nurseries at Carolinas HealthCare System Blue Ridge.
The ASAM Treatment of Opioid Use Disorder Course covers the highest quality, evidence- based practices for treating patients
with opioid use disorder. The combined online enduring material and live activity will provide the required 8 hours needed to
obtain the waiver to prescribe buprenorphine in office-based treatment of opioid use disorder. The curriculum for this course
has been specifically designed for women’s health providers.
The ASAM Treatment of Opioid Use Disorder Course is designed for:
• Physicians, nurse practitioners, physician assistants, and clinical nurse specialists who wish to obtain a waiver to prescribe buprenorphine in office-based treatment of opioid use disorder.
• Clinicians and healthcare team members working with providers who prescribe buprenorphine in office-based treatment of opioid use disorder.
• Assess patients for the full spectrum of harmful opioid use including misuse and use disorders.
• Describe procedures for initiating, stabilizing, maintaining, monitoring and modifying treatment of patients on buprenorphine or naltrexone.
• Describe unique issues of treating adolescents, young adults, pregnant and postpartum patients maintained on medications for opioid use disorder.
• Apply for a waiver to prescribe buprenorphine to patients with opioid use disorder.
Schedule (in conjunction with 4-hour online course):
7:55am-12:30pm Treatment of Opioid Use Disorder Course (Nathan Mullins, MD)
9:30am-10:00am Break / Networking
ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training.
ACCME ACCREDITATION STATEMENT: The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA CREDIT DESIGNATION STATEMENT: The American Society of Addiction Medicine designates this enduring material for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The American Society of Addiction Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
DATA 2000 training provided through the UNC Extension for Community Health Care Outcomes for Rural Primary Care Medication Assisted Treatment (UNC ECHO for MAT) is made possible by funding from the Agency for Healthcare Research and Quality (AHRQ) Grant number: 1R18HSO25065-01.